Novacyt Saham

Novacyt Modal Kerja

Modal Kerja dari Novacyt (ALNOV.PA) pada 15 Agu 2026 adalah 29,39 Juta. GBP. Tahun sebelumnya, Modal Kerja adalah 56,88 Juta. GBP — perubahan sebesar -48,33% (lebih rendah).

Modal Kerja

29,39 Juta.GBP

YoY

-48,33%

Terakhir Diperbarui:

Modal Kerja dari Novacyt adalah 2026 29,39 Juta. GBP. Modal Kerja dari Novacyt adalah 2025 56,88 Juta. GBP. Menurun -48,33% lebih rendah dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Novacyt Analisis saham

Apa yang dilakukan Novacyt? Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. The company was founded in 2006 and has experienced impressive growth since then. Its headquarters are located in Paris. Novacyt's business model revolves around the development and marketing of diagnostic products and technologies, particularly molecular diagnostic kits and reagents used for identification and quantification of microorganisms, viruses, and genetic differences. These products are commonly used in medical research, clinical diagnostics, and environmental analysis. Novacyt is divided into several divisions, each offering different products and services. Its diagnostic business specializes in the research, development, and marketing of molecular diagnostic kits, including the Primerdesign Kits specifically designed for COVID-19 identification. The company also provides laboratory and service offerings, such as DNA sequencing, qPCR analysis, sample preparation, and PCR disinfection. Additionally, Novacyt offers various diagnostic tests capable of detecting genetic differences and mutations. Its PathFlow division focuses on improving the process from diagnosis to therapy and follow-up, particularly for oncology patients. In response to the COVID-19 pandemic, Novacyt quickly launched a PCR test kit for COVID-19, which has been approved in numerous countries worldwide. Novacyt has successfully established itself as a key player in the fight against the pandemic. In summary, Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. Through its divisions, the company ensures the optimal utilization of molecular diagnostic tests. Novacyt has become an important player in the fight against the pandemic through its rapid response and development of molecular diagnostic kits for COVID-19, establishing itself as a reliable and innovative partner for medical research and clinical diagnostics. Novacyt adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Novacyt

Modal Kerja Novacyt adalah 29,39 Juta. GBP pada tahun 2026.

Modal Kerja dari Novacyt berubah dari 56,88 Juta. GBP menjadi 29,39 Juta. GBP, mewakili perubahan -48,33%. Nilainya lebih rendah daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Modal Kerja Novacyt sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Modal kerja adalah perbedaan antara aset lancar dan kewajiban lancar. Modal kerja positif menunjukkan perusahaan dapat memenuhi kewajiban jangka pendeknya.

GBP Modal Kerja adalah faktor kunci bagi investor. Perubahan metrik ini dapat menunjukkan fundamental yang membaik atau memburuk, secara langsung memengaruhi harga saham. Di Eulerpool, Anda dapat melacak Novacyt Modal Kerja secara historis dan real-time.

Access this data via the Eulerpool API

Neraca — Novacyt

Semua Metrik Kunci — Novacyt